ð ç« æ«éèš
- Acinetobacter baumannii â gram - coccobacillus, oxidase NEG, ICU/burn/vent/æ°å Ž
- WHO critical priority, MDR > Pseudomonas
- äž»èŠ syndromes: VAP/HAP, bacteremia, wound, meningitis (post-NSx)
- OXA carbapenemases: OXA-23, 24/40, 58 â Acinetobacter-specific
- Treatment 2023:
- Sulbactam-durlobactam (Xacduro) + imipenem â first-line CRAB
- Cefiderocol â alternative
- High-dose amp-sulbactam, polymyxin (last)
- Combination therapy common
- Dry surface 1 month+ â environmental cleaning + isolation
- éå¥ Pseudomonas: oxidase NEG, coccobacillus, no pigment
- Combat / æ°å Ž â Ukraine 2022+ outbreaks